Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
17.46%
↑ 135% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthAccelerating
Average
-49.81%
Historical baseline
PeriodValue
202517.46%
2024-3.68%
2023-12.47%
2022-71.05%
2021-96.11%
2020-28.41%
2019-17.06%
2018-30.64%
2017-116.28%
2016-139.83%